Drug · DIN 02474875
XULTOPHY
PREFILLED PEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 31, 2025; first marketed June 6, 2018.
- Drug Identification Number (DIN)
- 02474875
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin degludec and liraglutide A10AE56
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN DEGLUDEC | 100 UNIT | ML |
| LIRAGLUTIDE | 3.6 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 11, 2018: NOC 20731New Drug Submission (NDS)